Search research articles
Contact Us
Filters
Showing results (381-390 of 527) with videos related to
Page
of 53
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2019
Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer
Richard S Finn, Yuan Liu, Zhou Zhu, et al.
Cancer Cell
|
March 15, 2011
Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening
Eric T Sawey, Maia Chanrion, Chunlin Cai, et al.
Journal of the American College of Surgeons
|
April 6, 2011
Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma
Johnny C Hong, Henrik Petrowsky, Fady M Kaldas, et al.
The Journal of Allergy and Clinical Immunology
|
March 22, 2017
Absence of functional fetal regulatory T cells in humans causes in utero organ-specific autoimmunity
Eric J Allenspach, Laura S Finn, Mara H Rendi, et al.
The Journal of Allergy and Clinical Immunology. Global
|
September 10, 2024
Granulomatous hyperinflammatory state induced by dupilumab treatment for eosinophilic esophagitis
Kanak V Kennedy, Anna Costello, Melissa A Lerman, et al.
JAMA Oncology
|
October 5, 2023
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial
Shukui Qin, Masatoshi Kudo, Tim Meyer, et al.
Biochemical Pharmacology
|
September 14, 1999
Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
J T Lim, G A Piazza, E K Han, et al.
Scientific Reports
|
November 24, 2019
Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance
S Inder, M Bates, N Ni Labhrai, et al.
Future Oncology (London, England)
|
November 2, 2023
The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results
Hope S Rugo, Seock-Ah Im, Anil A Joy, et al.
The Oncologist
|
January 24, 2021
Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up
Richard S Finn, Hope S Rugo, Karen A Gelmon, et al.
Page
of 53
Search research articles
Search
Showing results (381-390 of 527) with videos related to
Sort By:
Page
of 53
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2019
Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer
Richard S Finn, Yuan Liu, Zhou Zhu, et al.
Cancer Cell
|
March 15, 2011
Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening
Eric T Sawey, Maia Chanrion, Chunlin Cai, et al.
Journal of the American College of Surgeons
|
April 6, 2011
Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma
Johnny C Hong, Henrik Petrowsky, Fady M Kaldas, et al.
The Journal of Allergy and Clinical Immunology
|
March 22, 2017
Absence of functional fetal regulatory T cells in humans causes in utero organ-specific autoimmunity
Eric J Allenspach, Laura S Finn, Mara H Rendi, et al.
The Journal of Allergy and Clinical Immunology. Global
|
September 10, 2024
Granulomatous hyperinflammatory state induced by dupilumab treatment for eosinophilic esophagitis
Kanak V Kennedy, Anna Costello, Melissa A Lerman, et al.
JAMA Oncology
|
October 5, 2023
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial
Shukui Qin, Masatoshi Kudo, Tim Meyer, et al.
Biochemical Pharmacology
|
September 14, 1999
Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
J T Lim, G A Piazza, E K Han, et al.
Scientific Reports
|
November 24, 2019
Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance
S Inder, M Bates, N Ni Labhrai, et al.
Future Oncology (London, England)
|
November 2, 2023
The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results
Hope S Rugo, Seock-Ah Im, Anil A Joy, et al.
The Oncologist
|
January 24, 2021
Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up
Richard S Finn, Hope S Rugo, Karen A Gelmon, et al.
Page
of 53